Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study | Li Lab

J. Huang, M. Li, J. Li, Y. Tang, and W. Shi

doi:10.1016/j.jaad.2026.06.116

Abstract

An abstract is not currently available here. Please see the publisher’s article.

← Back to publications